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CBPThe transcription factor NF-κB family serves as a key component of many pathophysiological events such as in-
nate and adaptive immune response, inﬂammation, apoptosis, and oncogenesis. Various cell signals trigger acti-
vation of the regulatorymechanisms of NF-κB, resulting in its nuclear translocation and transcriptional initiation.
The diacylglycerol kinase (DGK) family, a lipid secondmessenger-metabolizing enzyme in phosphoinositide sig-
naling, is shown to regulate widely various cellular processes. Results of recent studies suggest that one family
member, DGKζ, is closely involved in immune and inﬂammatory responses. Nevertheless, little is known about
the regulatory mechanism of DGKζ on NF-κB pathway in cytokine-induced inﬂammatory signaling. This study
shows that siRNA-mediated DGKζ knockdown in HeLa cells facilitates degradation of IκB, followed by nuclear
translocation of NF-κB p65 subunit. In addition, DGKζ-deﬁcient MEFs show upregulation of p65 subunit phos-
phorylation at Serine 468 and 536 and its interaction with CBP transcriptional coactivator upon TNF-α stimula-
tion. These modiﬁcations of p65 subunit might engender enhanced NF-κB transcriptional reporter assay of DGKζ
knockdown cells. These ﬁndings provide further insight into the regulatorymechanisms of cytokine-induced NF-
κB activation.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The transcription factor nuclear factor-κB (NF-κB) plays a central
role in regulating inﬂammation, immune responses, cell growth and
survival, and tumorigenesis [1,2]. It is involved in various human dis-
eases and is targeted by several anti-inﬂammatory and anticancer
drugs. The NF-κB family includes p65 (RelA), RelB, c-Rel, p100/p52,
and p105/p50 and exists as heterodimeric or homodimeric proteins,
typically a heterodimer of p50 and RelA/p65 subunits. Under normal
conditions, NF-κB exists in the cytoplasm in an inactive form associated
with IκB inhibitory proteins. A variety of cellular stimuli such as cyto-
kines, lipopolysaccharide (LPS), and phorbol 12-myristate 13-acetate
(PMA) induce phosphorylation of IκB with a concomitant decrease in
IκB levels through the ubiquitin–proteasome system [3]. IκB phosphor-
ylation is regulated by theβ subunit ofmature IκB kinase (IKK) complex
composed of two catalytic subunits (IKKα and IKKβ) and a regulatory
subunit: IKKγ/NEMO [4]. This pathway is designated as the canonical
or classical pathway. After degradation of IκB, the released NF-κBell Biology, YamagataUniversity
, Japan. Tel.: +81 23 628 5207;
to).translocates into the nucleus and activates its gene transcription. At a
later time point, IκB levels were recovered because of the NF-κB tran-
scriptional response of the IκB promoter, thereby terminating its tran-
scriptional function [5]. In the non-canonical or alternative pathway,
IKKα is activated. It phosphorylates p100, generating p52 and RelB het-
erodimers, which translocate to the nucleus.
Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diac-
ylglycerol (DG) to generate phosphatidic acid (PA) [6–9]. Actually, DG is
well known to regulate various cellular functions through the DG-
responsive C1 domain, which is included in signaling molecules such
as protein kinase C (PKC) [10–13]. Because PA, the reaction product of
DGK, has also been reported to regulate many signaling proteins such
as Raf-1 andmTOR, DGK is probably a key regulator of these two signal-
ing molecules [14]. Of the DGK family, DGKζ is characterized by its
nuclear localization signal (NLS) and nuclear export signal (NES)
[15–18], suggesting that this isozyme shuttles between the nucleus
and the cytoplasm [19–24]. Recent reports have described that DGKζ
is intimately involved in immune and inﬂammatory responses
[25–28]. DGKζ-deﬁcient T cells are hyper-responsive to T cell receptor
stimulation [29]. Furthermore, DGKζ deﬁciency increases resistance to
endotoxin shock but enhances susceptibility to Toxoplasma gondii infec-
tion [30]. It remains to be determined how DGKζ is involved in NF-κB
pathway, which plays a critical role in inﬂammatory processes.
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mechanism of cytokine-induced NF-κB pathway. We demonstrate
that, upon stimulation with TNF-α, DGKζ knockdown or deletion en-
hances IKKβ phosphorylation and IκB degradation, thereby leading to
accelerated nuclear translocation and retention of the NF-κB p65 sub-
unit. Additionally, we found that DGKζ deﬁciency promotes enhanced
phosphorylation of p65 subunit and its association with CBP transcrip-
tional coactivator. These conditions increase NF-κB transcriptional ac-
tivity. The present data suggest that DGKζ is a negative regulator of
TNF-α-induced NF-κB pathway.
2. Materials and methods
2.1. Cell culture and reagents
Mouse embryonic ﬁbroblasts (MEFs) obtained from wild-type
(C57BL6) and DGKζ-KO mice were immortalized by transfection of
SV40 plasmid DNA [29,31,32]. HeLa cells, MEFs, and A549 cells were
grown at 37 °C and 5% CO2 in Dulbecco's modiﬁed Eagle's medium
(DMEM, Wako) with 10% heat-inactivated fetal bovine serum (FBS),
100 U/ml penicillin, 100 U/ml streptomycin sulfate. Following 4 h
serum starvation in DMEM containing 0.1% bovine serum albumin
(BSA), cells were treated with either 20 ng/ml TNF-α (Miltenyi Biotec)
or 50 ng/ml IL-1β (Miltenyi Biotec). In the control cells, 0.1% BSA vehicle
was added to the medium. Anti-DGKζ antibody was produced as de-
scribed previously [18,24]. Anti-NF-κB p65 (1:1000; #8242), anti-IκBα
(1:1000; #4814), anti-IKKα (1:1000; #2682), anti-IKKβ (1:1000;
#2370), anti-phospho-p65 Ser536 (1:1000; #3033), anti-phospho-
p65 Ser468 (1:1000; #3039), anti-phospho-IκBα Ser32 (1:1000;
#2850), anti-phospho-IKKα/β Ser176/180 (1:1000; #2697), anti-
phospho-Akt Ser473 (1:1000; #4060), anti-phosho-p38 MAPK
Thr180/Tyr182 (1:1000; #4511), anti-p38 MAPK (1:1000; #9212),
anti-phospho-ERK Thr202/Tyr204 (1:1000; #4370), anti-ERK (1:1000;
#4695), anti-phospho-JNK Thr183/Tyr185 (1:1000; #4668), and anti-
JNK (1:1000; #9252) antibodies were purchased from Cell Signaling
Technology. Anti-Rho GDIα (0.1 μg/ml, sc-360) and anti-Lamin B
(0.2 μg/ml, sc-6216) antibodies were from Santa Cruz Biotechnology.
Anti-β-actin (1:5000; AC-15) antibodywas obtained from Sigma Aldrich.
2.2. RNA silencing
Human speciﬁc DGKζ siRNAs (siDGKζ7: 5′-AUUGAGAUACCAGAGG
AAAGACUGG-3′, siDGKζ8: 5′-UAGAACAUCUUAUUCCGAAAGCGGC-3′)
were obtained from Life Technologies. Control siRNA (All stars negative
control)was purchased fromQiagen. The siRNAswere transfected using
RNAiMAX (Life Technologies).
2.3. Immunostaining
HeLa cells and MEFs were seeded onto coverslips in a 35-mm dish
for the experiments. The cells were ﬁxed with 4% paraformaldehyde
in PBS at room temperature (RT) for 15 min, permeabilized with 0.1%
Triton X-100/PBS for 15 min, and blocked with 5% normal goat serum
(NGS) for 20 min [33]. After washing with PBS three times, the cells
were incubated with rabbit anti-p65 NF-κB antibody followed by sec-
ondary antibody conjugated with Alexa 488 (Life Technologies). Immu-
noﬂuorescence images were obtained with a confocal laser microscope
(LSM510, Carl Zeiss).
2.4. Immunoblotting
Cells were washed with ice-cold PBS and then lysed in lysis buffer
composed of 100 mM Tris/HCl (pH 7.5), 150 mM NaCl, 0.5% sodium
deoxycholate, 0.1% SDS, 1% NP-40, 1 mM Na3VO4, 50 mM NaF, 1 mM
β-glycerophosphate, protease inhibitor cocktail (Sigma Aldrich). After
centrifugation for 10 min at 15,000 ×g at 4 °C, the supernatant wastransferred into a new tube and determined for the protein concentra-
tion using Pierce BCA Protein Assay Reagent (Thermo Fisher Scientiﬁc).
In some experiments, cell lysates were separated into cytosolic and nu-
clear fractions using the ProteoExtract subcellular proteome extraction
kit (Millipore) according to the manufacturer's instruction. Samples
were resolved by SDS-PAGE and transferred to a PVDF membrane
(Immobilon-P, Millipore). Themembranes were incubated with prima-
ry antibodies, and the immunoactive proteins were visualized by using
the Immobilon Western Chemiluminescent HRP Substrate (Millipore).
Band intensities were quantiﬁed by densitometry using image J (Na-
tional Institutes of Health, Bethesda) as described [34].
2.5. Luciferase reporter assay
HeLa cells were transfected with DGKζ siRNA (siDGKζ) or control
siRNA (siControl). After 24 h, the cells were then transfected with
pNF-κB-Luc (2 μg, Clontech) and pRL null (0.04 μg, TOYO INK) using Li-
pofectamine 2000 (Life Technologies) for further 24 h. Cells were stim-
ulated with TNF-α (20 ng/ml) for 8 h and lysed in PicaGene Dual Cell
Culture Lysis Reagent (TOYO INK) for 15 min at 4 °C. Cell extracts
were collected and cleared by centrifugation at 15,000 ×g, and protein
concentration was determined with the Pierce BCA Protein Assay Re-
agent. Renilla and ﬁreﬂy luciferase activities were measured using a
Luminescenncer-Octa (ATTO).
2.6. RT-PCR
Total RNA was extracted from wild-type (WT) and DGKζ-knockout
(KO) MEFs using TRIzol reagent (Life Technologies). First strand cDNA
was synthesized from 2 μg of total RNA using reverse transcriptase
(PrimeScript 1st strand cDNA Synthesis Kit, Clontech) according to the
manufacturer's instruction. Polymerase chain reaction ampliﬁcation
was performedwith Quick Taq HSDyeMix (Toyobo) using gene speciﬁc
oligonucleotide primers: mouse DGKζ: 5′-TTACACAGATGAGCCTGT
GTC-3′ (sense), 5′-GTTTCAGGTCCTGAATCTTGC-3′ (antisense); TNF-α:
5′-TAGCCCACGTCGTAGCAAAC-3′ (sense), 5′-AAGTAGACCTGCCCGGAC
TC-3′ (antisense); β-actin: 5′-CCCATGCCATCCTGCGTCTG-3′ (sense);
5′-CGTCATACTCCTGCTTGCTG-3′ (antisense). The PCR condition was
one cycle of pre-denaturation at 94 °C for 2 min followed by 25–28 cy-
cles of denaturation at 94 °C for 30 s, annealing at 58 °C for 30 s, and
elongation at 68 °C for 1min, and then at 68 °C for 10min. PCR products
were separated by 2% agarose gels, stained with ethidium bromide, and
visualized by Printgraph (ATTO).
2.7. Immunoprecipitation
Wild-type (WT) and DGKζ-KO MEFs were treated with or without
TNF-α (20 ng/ml) for 10 min. Cells were lysed in lysis buffer (20 mM
Tris–HCl, pH 7.4, 50 mM NaCl, 1 mM Na3VO4, 50 mM NaF, 1% Triton
X-100, and protease inhibitor cocktail). After centrifugation at 16,000 ×g
for 10 min 4 °C, the supernatant was transferred to a new tube and
mixed with protein A-Sepharose beads (GE Healthcare) for 1 h at 4 °C
to eliminate non-speciﬁc binding. Precleared supernatant (1 mg) was
mixed with 1 μg of rabbit anti-p65 NF-κB antibody and incubated with
protein A-Sepharose beads for 1 h. After washing with lysis buffer four
times, the immunocomplex was boiled for 10 min in SDS sample buffer
(New England Biolabs). The sample was applied to an SDS-PAGE gel
and subjected to immunoblot analysis.
3. Results
3.1. Subcellular dynamics of NF-κB p65 subunit under conditions of DGKζ
downregulation
Under resting conditions, NF-κB, consisting typically a heterodimer
of p65/RelA and p50 subunits, is sequestered in the cytoplasm in
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(NLS) of the p65 subunit. Consequently, nuclear translocation of NF-κB
is a critical regulatory step for transcriptional activity upon stimulation
[35]. Previous reports describe that following cellular exposure to TNF-
α, p65 subunit oscillates dynamically between the nucleus and the cyto-
plasm in an approximately 1 h cycle [36]. Therefore we examined
whether downregulation of DGKζmight affect the dynamics of NF-κB
p65 subcellular localization.
First, HeLa cells transfected with control (siControl) or DGKζ siRNA
(siDGKζ) were subjected to the time course analysis of p65 subunit im-
munocytochemistry following TNF-α stimulation (Fig. 1). Under resting
conditions, p65 staining was detected primarily in the cytoplasm in
both control and DGKζ knockdown cells. In the control cells, p65 sub-
unit was partially observed in the nucleus at 15 min of stimulation
and became dominant to the nucleus, peaking at 30 min. Thereafter,
at 60min, the p65 subunit was evenly distributed in the nucleus and cy-
toplasm or rather dominantly in the cytoplasm. However, in DGKζ
knockdown cells, TNF-α stimulation accelerated the nuclear transloca-
tion of p65 subunit: p65 staining was observed predominantly in the
nucleus at 15 and 30 min, and nuclear dominant staining of p65
remained in approximately 50% of cells at 60 min.T
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Fig. 1. Effect of RNA silencing of DGKζ on NF-κB p65 subcellular dynamics following TNF-α stim
siRNA (si DGKζ). After 48h, cellswere stimulatedwith TNF-α (20 ng/ml). Cellswereﬁxedwith 4
antibody. Scale bars, 10 μm. (B) Fifty cells were counted for the subcellular localization of p65 s
dominant (nucleus ≤ cytoplasm). The presented data are mean ± SD of three separate experim
tically signiﬁcant.We performed the same experiment in DGKζ-deﬁcient MEFs. As
presented in Fig. 2, in DGKζ-nullMEFs, thep65 subunitwas translocated
promptly to the nucleus, where it was retained for a longer time than
wild-type cells, which is more clearly observed compared with DGKζ
knockdown cells. We also stimulated cells with IL-1β, which produced
similar results (Supplementary Fig. 1).
We next complemented these morphological experiments by bio-
chemical analyses. After 15 min of TNF-α stimulation, the time point
of maximum p65 nuclear translocation, cell lysates were fractionated
into cytosolic (cyt) and nuclear (nuc) fractions, which were subjected
to immunoblot analysis with p65 antibody. Similar to the immunohisto-
chemical data, p65-immunoreactive band in the nuclear fraction was
more intense in DGKζ-KO MEFs (Fig. 2C, lane 4) compared with that
in wild-type MEFs (lane 2). Collectively, these results suggest that
DGKζ downregulation promotes nuclear translocation of the NF-κB
p65 subunit and prolongs its nuclear retention.
3.2. DGKζ downregulation facilitates IκB degradation
Recently, two distinct NF-κB activation pathways have been identi-
ﬁed, i.e., the classical and alternative NF-κB signaling pathways [2]. Ofime (min)
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ysis using anti-p65, anti-RhoGDIα (cytosolicmarker), and anti-Lamin B (nuclearmarker). Immunoreactive bands of IκBαwere quantiﬁed by densitometry and normalized to the value of
sample in cytosolic fraction of each MEF. A representative result of at least three repeated experiments is shown.
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365R. Tsuchiya et al. / Biochimica et Biophysica Acta 1853 (2015) 361–369the two pathways, classical NF-κB activation is regulated by inducible
IκB degradation. This pathway can be activated rapidly and transiently
by various stimuli such as mitogens and cytokines. IκB degradation en-
genders unmasking of theNLS of NF-κB p65 subunit, thereby facilitating
its nuclear translocation. Because NF-κB nuclear translocation is report-
ed to be closely associated with IκB degradation, we examined the time
course changes in the levels of IκB in control and DGKζ knockdown cells
after stimulation with TNF-α (Fig. 3A). In control cells, IκB levels were
decreased to about 40–50%of resting levels at 15–30min of TNF-α stim-
ulation and returned to 70% at 60 min. However, in DGKζ knockdown
cells, IκB levels were massively attenuated to less than 10% of resting
levels and were recovered to at most 30% at 60 min. Similar results
were obtained for the experiment using another cell line, A549 cells de-
rived from human alveolar adenocarcinoma (Supplementary Fig. 4).
Furthermore, we conﬁrmed these ﬁndings in the experiments using
DGKζ-deﬁcient MEFs with stimulation of TNF-α (Fig. 3B) and IL-1β
(Supplementary Fig. 2).
We next performed rescue (add-back) experiments using rat DGKζ,
which is resistant to siDGKζ for human sequence (Supplementary
Fig. 5). Reintroduction of wild-type rat DGKζ in siDGKζ-treated HeLa
cells reverted IκB downregulation after TNF-α stimulation (lane 6 ver-
sus lane 4) to the extent of the control level (lane 2). It should be
noted that reintroduction of catalytically inactive rat DGKζ (rDGKζ-KD)
in siDGKζ-treated HeLa cells also reverted IκB expression after TNF-α
stimulation to the extent ofwild-type rDGKζ and the control levels (Sup-
plementary Fig. 6, lane 6 versus lanes 4 and 2). Taken together, the re-
sults suggest that DGKζ downregulation facilitates IκB degradation
following cytokine stimulation and that DGKζ exerts a regulatory effect
on IκB levels independently of its kinase activity.
3.3. Phosphorylation of NF-κB regulatory components is facilitated by DGKζ
downregulation
Phosphorylation targets IκB for ubiquitination followed by
proteasome-mediated degradation [3,37,38]. IκB kinase (IKK) is theA
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Fig. 3. Effect of DGKζ downregulation on IκB expression after TNF-α stimulation. HeLa
cells transfected with control siRNA (siCont) or DGKζ siRNA (si DGKζ) for 48 h (A) and
MEFs from wild-type (WT) or DGKζ-deﬁcient (DGKζ-KO) mice (B) were stimulated
with TNF-α (20 ng/ml). Cells were collected at the time points indicated and the lysates
were subjected to immunoblot analysis (20 μg protein/lane) using anti-IκBα antibody.
Anti-β-actin antibody was used as a control. Immunoreactive bands of IκBαwere quanti-
ﬁed by densitometry and normalized to the value of sample at 0 min obtained in siCont-
treated or WT MEFs. A representative result of at least three repeated experiments is
shown.protein kinase complex responsible for IκB phosphorylation in response
to proinﬂammatory stimuli [39]. IKK is a multisubunit complex that in-
cludes two catalytic subunits, IKKα and IKKβ. An earlier study showed
that IKKβ is responsible for the proinﬂammatory cytokine-induced acti-
vation of NF-κB [40]. Themechanisms that activate the IKK complex are
not understood completely, but activation is known to require phos-
phorylation of the IKKβ activation loop [41].
Therefore we next investigated the phosphorylation status of IKK,
together with NF-κB p65 subunit, in DGKζ-deﬁcient MEFs during TNF-
α stimulation (Fig. 4). Because IκB degradation was observed in the
early phase of stimulation (15–30min), as depicted in Fig. 3, we specif-
ically examined the time points within the ﬁrst 15 min. IκB attenuation
was observed at 10 min of stimulation in wild-type MEFs, although it
became apparent at 5 min in DGKζ-deﬁcient MEFs. Consistent with
this time course, phosphorylation of IKKβ (upper band) was increased
at 5–10 min in DGKζ-deﬁcient MEFs, although IKKα phosphorylation
(lower band) showed no marked changes between wild-type and
DGKζ-deﬁcient MEFs. Furthermore, the results show that p65 subunit
phosphorylation at Ser536 was upregulated at 5–10 min in DGKζ-
deﬁcient MEFs; so was phosphorylation at Ser468 shortly later at
10–15min. These results suggest that DGKζ deletion activates the phos-
phorylation reaction of the regulatory components of NF-κB pathway.
NF-κB transactivation is reportedly mediated by the activation of
mitogen-activated protein kinase (MAPK), PI3K-Akt and PKC pathways
[2,39]. Therefore we next examined several of those upstream kinases
responsible for increased phosphorylation of IKKβ and p65 subunit
after TNF-α stimulation. We used the same experimental design as
that shown in Fig. 4, which enables us to examine the upstream kinases
using p38 MAPK, ERK, and Akt antibodies. As presented in Fig. 5, phos-
phorylation levels of p38 MAPK and ERK were apparently increased
slightly at 10–15 min in DGKζ-deﬁcient MEFs compared with the
wild-type one. Akt phosphorylation showed no apparent differences
between the two groups (data not shown).
Regarding involvement of PKC, thrombin induces PKC-δ activation in
endothelial cells. This event is necessary for IKKβ and p38MAPK activa-
tion [42]. Furthermore, PKC-δ-dependent activation of IKKβ and p38
MAP kinase contributes to the mechanism of thrombin-induced ICAM-
1 expression by activating NF-κB in the cytoplasm and increasing the
transactivation potential of NF-κB p65 subunit in the nucleus. Therefore,p-IKK /
(Ser176/180) p-IKK 85 kDa
p-IKK 87 kDa
IKK
IKK
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Fig. 4. Effect of DGKζ deﬁciency on thephosphorylation status of p65 subunit and IKK after
TNF-α stimulation. Subconﬂuent wild-type (WT) or DGKζ-deﬁcient (DGKζ-KO) MEFs
were stimulated with TNF-α (20 ng/ml). Cells were collected at the time points indicated
and subjected to immunoblot analysis (20 μg protein/lane) using anti-phospho-p65
(Ser468), anti-phospho-p65 (Ser536), anti-p65 (total), anti-IκBα, anti-IΚΚα, anti-IΚΚβ,
and anti-phospho-IΚΚα/β (Ser176/180), antibodies. Bands for phospho-IKKβ and -IKKα
were indicated by arrows. Anti-β-actin antibody was used as a control.
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Fig. 5. Effect of DGKζ deﬁciency on the phosphorylation status of upstream kinases after
TNF-α stimulation. Samples obtained in Fig. 4 were subjected to immunoblot analysis
using anti-p38 MAPK, anti-phosho-p38 MAPK Thr180/Tyr182, anti-ERK, and anti-
phospho-ERK Thr202/Tyr204 antibodies. Anti-β-actin antibody was used as a control.
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lation of IκB and p65, together with IκB degradation, in DGKζ-deﬁcient
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A3.4. DGKζ knockdown enhances the association of p65 subunit with CBP
and NF-κB transactivation activity
Having shown that DGKζ downregulation/deletion promotes NF-kB
p65 subunit nuclear translocation, prolongs its nuclear retention, and
upregulates p65 phosphorylation, we next asked whether these condi-
tions modulate the association of p65 subunit with CBP/p300 coactiva-
tor and subsequent NF-κB transactivation activity. An earlier study
showed that p65 phosphorylation at Ser536 and/or Ser276 promotes
enhanced interaction of p65 subunit and CBP/p300 and the following
NF-κB transcriptional activation [43]. Therefore, we ﬁrst performed
the coimmunoprecipitation experiments with DGKζ-deﬁcient MEFs
(Fig. 6). The results showed that DGKζ deletion enhances the associa-
tion of p65 subunit with CBP signiﬁcantly after 10 min stimulation
with TNF-α compared with wild-type MEFs. It is noteworthy that thisTNF- -      +    -      +
WT DGK -KO 
IP: p65 
IB: CBP 
IB: -actin
IB: DGK
IB: p65 
IB: CBP 
cell 
lysate 
IB: p65 
Fig. 6. Effect of DGKζ deﬁciency on the association of p65 subunit and transcriptional
coactivator CBP. Subconﬂuent wild-type (WT) or DGKζ-deﬁcient (DGKζ-KO) MEFs were
treated with or without TNF-α (20 ng/ml) for 10 min. The lysates were mixed with
anti-p65 antibody combined with protein-G-Sepharose beads and incubated for 6 h
at 4 °C. Cell lysates and the immunoprecipitates were analyzed by immunoblotting
using anti-CBP and anti-p65 antibodies. Anti-β-actin antibody was used as a control. IP,
immunoprecipitation; IB, immunoblot.association was also evident in the absence of TNF-α stimulation.
These ﬁndings suggest that p65 subunit closely associates with CBP in
the absence or presence of stimulation. We next performed the NF-κB
luciferase reporter assay using DGKζ knockdown cells (Fig. 7). HeLa
cells were transfected with either siControl or siDGKζ along with NF-κB
reporter and internal control pRL. In the control cells, NF-κB transcription-
al activitywas increased approximately 5-fold after TNF-α stimulation. In
contrast, in DGKζ knockdown cells, the activity was increased 8–12-fold
after stimulation. Additionally, RT-PCR analysis showed prominent up-
regulation of NF-κB target gene TNF-αmRNA levels in DGKζ-null MEFs
compared with the wild-type one (Fig. 8).
4. Discussion
The results of this study demonstrated that DGKζ downregulation
engenders enhancement of NF-κB pathway in response to cytokines
such as TNF-α and IL-1β. In response to these cytokines, the NF-κB
p65 subunit is accelerated for its nuclear translocation, which repre-
sents the major regulatory step for the activation, under DGKζ-
knockdown or DGKζ-deﬁcient conditions. In addition, DGKζ deﬁciency
promotes enhanced interaction of p65 subunit with CBP coactivator.
The resulting prolonged retention of p65 subunit in the nucleus, togeth-
er with its enhanced association with transcriptional coactivator, might
engender augmented NF-κB transactivation activity upon cytokine
stimulation.
NF-κB has often been termed a ‘central mediator of the immune re-
sponse’ because it regulates the expression of inﬂammatory cytokines,
chemokines, immunoreceptors, and cell adhesion molecules [44]. This
fact indicates that NF-κB induces the expression of inﬂammatory cyto-
kines and chemokines, and in turn, is induced by them, suggesting a0 
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ings demonstrate clearly that DGKζ knockdown or deletion accelerates
this positive feedback mechanism for NF-κB. These conditions might
provide the basis for chronic or excessive inﬂammatory conditions
such as rheumatoid arthritis, asthma, and inﬂammatory bowel disease
[45].
Of the DGK family, previous studies have shown that DGKα and
DGKζ are abundantly expressed in the immune system [15,46]. Both
of these isozymes are proposed to exert a suppressive effect on T cell re-
ceptor (TCR) response [47,48]. In T cells, DGKα and DGKζ inhibit DG-
mediated signaling following TCR engagement and prevent T-cell hy-
peractivation. Consequently, DGKα and DGKζ synergistically promote
T-cell anergy and are critical for T-cell tolerance [25]. Suppressive effects
of DGKζ on T cells are revealed by the phenotype of DGKζ-deﬁcient
mice, which show Ras/MAPK activation, together with enhanced ex-
pression of the CD69 and CD25 activation markers [29].
In dendritic cells and macrophages, however, DGKζ positively regu-
lates Toll-like Receptor (TLR)-induced proinﬂammatory cytokine pro-
duction through its product PA [30]. Earlier studies have shown that
both DG and PA are produced in macrophages following LPS (a TLR4
ligand) and lipopeptide (a TLR2 ligand) stimulation [49–51]. TLR-
mediated responses are crucially important for host defense againstmi-
crobial organisms such as T. gondii. Host defense against this organism is
initiated by dendritic cells, macrophages, and other antigen-presenting
cells after recognition of pathogen-associated molecular patterns
through TLR2 and TLR11. Deﬁciency of these TLRs increases host sus-
ceptibility to T. gondii infection [52,53]. TLR signaling and the subse-
quent production of IL-12 by immune cells induce Th1 adaptive
immune responses and IFN-γ production, which provides critical resis-
tance to T. gondii infection [54]. In this regard, DGKζ deﬁciency report-
edly results in impaired cytokine (IL-12 and TNF-α) production
following TLR stimulation, increased resistance to endotoxin shock,
and enhanced susceptibility to T. gondii infection [30]. The increased
susceptibility of DGKζ-deﬁcient mice to T. gondii infection is apparently
correlatedwith inhibition of Th1 immune responses in vivo [30]. Collec-
tively, previousﬁndings demonstrate thatDGKζ exerts a suppressive ef-
fect on TCR through DG metabolism in T cells, although it exerts a
positive effect on TLR-induced proinﬂammatory cytokine production
through its product PA in dendritic cells and macrophages.
This study shows that DGKζ deﬁciency enhances TNF-α-induced
NF-κB signalingpathway inHeLa cells. The remarkable diversity of stim-
uli is well known to engender activation of NF-κB, which might be me-
diated by signaling cascades that culminate in IKK activation, the ﬁnal
common pathway for the NF-κB activation. In this regard, we found
that upon TNF-α challenge, DGKζ deﬁciency selectively activates the
IKKβ subunit while leaving IKKα phosphorylation unchanged. This re-
sult suggests that DGKζ exerts a suppressive effect on the canonical
NF-κB pathway. TLR signalings are mediated by the myeloid differenti-
ation primary response protein 88 (MyD88)-dependent pathway,
which is used by most TLRs except TLR3 [55]. This pathway is initiatedafter association of MyD88 with the TLRs during microbial recognition.
MyD88 in turn recruits IL-1R-associated kinase 1 and 4 (IRAK1&4),
TNFR-associated factor 6 (TRAF6), and other signaling molecules, lead-
ing to IKK complex activation. Considering previous and present ﬁnd-
ings together, they can be summarized as follows: DGKζ deﬁciency
enhances TNF-α-induced NF-κB transactivation, but reduces TLR-
mediated NF-κB pathway. These ﬁndings suggest that 1) DGKζ exerts
positive and negative effects on the canonical pathway of NF-κB activa-
tion in a context-dependent manner; and 2) DGKζ acts on some up-
stream molecule(s) of IKK complex phosphorylation.
DGKα is also involved in theNF-κB signaling [56,57]. DGKα is shown
to regulate TNF-α-dependent NF-κB activation positively in AKI mela-
noma cells, which contrasts sharply to the effect exerted by DGKζ.
How do these DGK isozymes exert opposite effects on the NF-κB signal-
ing pathway under the same stimulation? Clues to address this issue
might be provided by their different regulatory mechanisms on the
IκB and the phosphorylation events of p65 subunit. DGKα knockdown
exerts no apparent effect on IκB protein levels, suggesting that DGKα
does not inﬂuence subcellular dynamics of the p65 subunit. In contrast,
DGKζ deﬁciency engenders facilitated degradation of IκB by IKKβ acti-
vation, thereby causing enhanced p65 nuclear translocation. With re-
gard to the phosphorylation events, p65 subunit is well known to be
subjected to phosphorylation at several sites, including Ser276 [58,59],
Ser311 [60], Ser468 [61], Ser529 [62], and Ser536 [63]. Of those, phos-
phorylation sites at Ser276, Ser311, Ser529, Ser468, and Ser 536 might
modulate the transcriptional activity. In this respect, DGKα depletion
attenuates the phosphorylation levels of Ser311, but does not affect
those at Ser468 and Ser536. In this case, decreased phosphorylation at
Ser311 is apparently mediated by PKCζ that is activated directly by PA
[60,64], which engenders downregulation of NF-κB transcriptional ac-
tivity [57]. On the other hand, DGKζ deﬁciency causes elevated levels
of the phosphorylation of p65 subunit at Ser468 and Ser536,which is re-
portedly mediated by IKK complex [39,63,65], thereby contributing to
upregulation of NF-κB activity. Pan-PKC inhibitor has no apparent effect
on IκB degradation and p65-Ser536 phosphorylation in DGKζ-deﬁcient
MEFs, suggesting that DGKζ has no regulatory effect on PKCs in this case
(Supplementary Fig. 3). Furthermore, our add-back experiments reveal
that catalytically inactive DGKζ-KD as well as wild-type DGKζ reverts
IκB expression after TNF-α stimulation (Supplementary Fig. 6). This
ﬁnding raises a possibility that DGKζ functions as a scaffold protein to
regulate IκB degradation, although detailed analysis remains to be
done as to whether catalytically inactive DGKζ-KD reverts the pheno-
type on phosphorylation events of p65 subunit and IKKβ, together
with CBP association and NF-κB transactivation activity. These results
suggest that, under inﬂammatory conditions, DGKα and DGKζ act on
distinct molecules involved in NF-κB pathway, respectively producing
positive and negative regulation.
Another ﬁnding of this work is that DGKζ deﬁciency enhances the
association of p65 subunit with the transcriptional coactivator CBP,
which might contribute to accelerated transactivation activity. This as-
sociation is shown to be promoted by phosphorylation of p65 at
Ser536 and/or Ser276 [43]. In this regard, we ﬁnd increased phosphor-
ylation at Ser536 after TNF-α stimulation in DGKζ-deﬁcientMEFs. How-
ever, DGKζ deﬁciency enhances the association of p65 subunitwith CBP,
even under basal conditions in the absence of TNF-α stimulation. How
can this phenotype be explained? One possibility is that DGKζ deﬁcien-
cy might modulate phosphorylation of p65 subunit at Ser276, which is
mediated by either protein kinase A (PKA) or mitogen-activated and
stress-activated protein kinase-1 (MSK1) [59,66].
The other possibility involves previous observations that NF-κB p65
subunit and tumor suppressor p53 compete for limiting quantities of
complexes containing the CBP/p300 coactivator proteins [67,68]. Both
NF-κB and p53 are activated in response to similar stimuli, such as
DNA damage and TNF-α [4]. p53 is generally a proapoptotic transcrip-
tional factor whereas NF-κB promotes resistance to programmed cell
death under most circumstances [69,70]. It is therefore suggested that
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cell proliferates or undergoes apoptosis [71]. In this regard, we reported
previously that DGKζ deletion upregulates 53 protein levels under basal
and DNA-damage conditions but simultaneously suppresses p53 tran-
scriptional activity [72,73]. Together with the present ﬁndings, DGKζ
deﬁciency augments transcriptional activity of NF-κB but attenuates
that of p53. These features of DGKζ-deﬁcient conditions might be ex-
plained by the hypothesis that DGKζ plays a role in sequestration of
the limiting pool of CBP/p300 between p65 subunit and p53 and that
DGKζ deﬁciency shifts CBP/p300 toward NF-κB p65 subunit to regulate
the reciprocally antagonistic phenotypes of these transcription factors
in an as yet unknownmechanism. However, this is not thewhole expla-
nation for the cross talk that happens between them because many
other inducible transcription factors have been reported that also inter-
actwith CBP/p300 [74–76]. Further investigationmust be undertaken to
assess how DGKζ regulates sequestration of CBP/p300 transcriptional
coactivators among various transcription factors to integrate the diverse
functions of all these proteins.
Uncertainty remains in relation to the activation process of IKKβ
under DGKζ-deﬁcient conditions. Reportedly, the IKK complex is phos-
phorylated by upstream kinases such as MEKK1 [77], MEKK3 [78], and
TGF-β-activated kinase 1 (TAK1) [79], NF-κB inducible kinase (NIK)
[77], and Akt [80]. In this study, DGKζ-KOMEFs show slightly increased
phosphorylation levels on p38 and ERK, although it remains undeter-
mined whether such level of upregulation is sufﬁcient to activate IKKβ
or not. It also remains to be elucidated how the acetylation status for
p65 subunit and histone proteins is modulated by enhanced association
with CBP coactivator. Further studies are necessary to elucidate these
issues.
5. Conclusion
This study revealed that DGKζ downregulation engenders facilita-
tion of nuclear transport of p65 subunit and its interaction with CBP
transcriptional coactivator upon cytokine stimulation, thereby enhanc-
ing NF-κB transactivation activity. These conditions might produce an
augmented positive feedback mechanism of cytokine-induced NF-κB
activity, which might cause aberrant NF-κB activation. Investigations
must be conducted to ascertain detailed molecular mechanism of
DGKζ on NF-κB pathway and how these NF-κB dynamics under DGKζ
downregulation engender disorganized responses at the organism level.
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